Algal polysaccharide's potential to combat respiratory infections caused by Klebsiella pneumoniae and Serratia marcescens biofilms

Appl Biochem Biotechnol. 2022 Feb;194(2):671-693. doi: 10.1007/s12010-021-03632-7. Epub 2021 Aug 27.

Abstract

The growth of respiratory diseases, as witnessed through the SARS and COVID-19 outbreaks, and antimicrobial-resistance together pose a serious threat to humanity. One reason for antimicrobial resistance is formation of bacterial biofilms. In this study the sulphated polysaccharides from green algae Chlamydomonas reinhardtii (Cr-SPs) is tested for its antibacterial and antibiofilm potential against Klebsiella pneumoniae and Serratia marcescens. Agar cup assay clearly indicated the antibacterial potential of Cr-SPs. Minimum inhibitory concentration (MIC50) of Cr-SPs against Klebsiella pneumoniae was found to be 850 µg/ml, and it is 800 µg/ml in Serratia marcescens. Time-kill and colony-forming ability assays suggest the concentration-dependent bactericidal potential of Cr-SPs. Cr-SPs showed 74-100% decrease in biofilm formation in a concentration-dependent manner by modifying the cell surface hydrophobic properties of these bacteria. Cr-SPs have also distorted preformed-biofilms by their ability to interact and destroy the extra polymeric substance and eDNA of the matured biofilm. Scanning electron microscopy analysis showed that Cr-SPs effectively altered the morphology of these bacterial cells and distorted the bacterial biofilms. Furthermore reduced protease, urease and prodigiosin pigment production suggest that Cr-SPs interferes the quorum sensing mechanism in these bacteria. The current study paves way towards developing Cr-SPs as a control strategy for treatment of respiratory tract infections.

Keywords: Algal polysaccharides; Biofilm eradication; Biofilm inhibition; Extra polymeric substance (EPS); Quorum sensing interference; Respiratory tract infections (RTIs).

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Chlorophyta / chemistry
  • Humans
  • Klebsiella pneumoniae / growth & development
  • Klebsiella pneumoniae / pathogenicity
  • Microbial Sensitivity Tests
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology*
  • Quorum Sensing / drug effects*
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / microbiology
  • SARS-CoV-2 / drug effects
  • Serratia marcescens / growth & development
  • Serratia marcescens / pathogenicity

Substances

  • Anti-Bacterial Agents
  • Polysaccharides